Truist raised the firm’s price target on American Healthcare REIT (AHR) to $38 from $32 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s estimates on Healthcare REITs. Truist is projecting a 12.0% year-over-year same-store net operating income growth in 2025, consistent with the management’s 9%-13% guidance range, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $45 from $37 at Morgan Stanley
- American Healthcare REIT: Strong Financial Performance and Strategic Acquisitions Drive Buy Rating
- American Healthcare REIT price target raised to $40 from $35 at Citizens JMP
- American Healthcare REIT Reports Q1 2025 Results, Raises Guidance
- American Healthcare REIT Reports Q1 2025 Financial Results